SMTL ID : 6mau.1

Crystal structure of human BRD4(1) in complex with CN210 (compound 19)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.11 Å

Oligo State

monomer

Ligands

1 x JBS: 1-(4-{6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-[(3S)-3-phenylmorpholin-4-yl]quinazolin-2-yl}-1H-pyrazol-1-yl)-2-methylpropan-2-ol(Non-covalent)

JBS.1: 11 residues within 4Å: Chain A: W.40, P.41, F.42, V.46, L.51, L.53, Y.56, C.95, N.99, I.105, M.108 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.40, A:P.41, A:F.42, A:L.51, A:L.53, A:I.105 Hydrogen bonds: A:N.99 Water bridges: A:Y.56 pi-Stacking: A:W.40

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94, I.97 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62, A:N.94 Water bridges: A:T.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, S.M. et al., Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases. Bioorg. Med. Chem. Lett. (2019)

Release Date

2019-04-03

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence